Products and Resources Catalog

  The Great Lakes Current is the e-newsletter of the Great Lakes ATTC, MHTTC, and PTTC.   The July 2023 issue honors National Minority Mental Health Awareness Month and World Hepatitis Day (July 28) by sharing events and resources on these topics. This issue also features newly released episodes from the Checking-In Podcast that focus on PTSD treatment providers' self-care and a new HealtheKnowledge course developed by the Great Lakes ATTC: NIATx Change Leader Academy: Rapid-Cycle Change for Teams.    As always, you will find links to all upcoming events and trainings hosted by the Great Lakes ATTC, MHTTC, and PTTC!  

  The Great Lakes Current is the e-newsletter of the Great Lakes ATTC, MHTTC, and PTTC.   The June 2023 issue honors National Pride Month, National PTSD Awareness Month, and Men's Health Month by sharing events and resources on these topics. As always, you will find links to all upcoming events and trainings hosted by the Great Lakes ATTC, MHTTC, and PTTC!  

This Supplemental Guide is developed as a supplement to Your Guide to Integrating HCV Services into Opioid Treatment Programs. The purpose of these two resources is to build the capacity of publicly funded Opioid Treatment Programs (OTPs) to integrate Hepatitis C Virus (HCV) prevention and treatment services into their programs. The opioid epidemic has resulted in significant increases in HCV among people who inject drugs, accounting for 23% of new infections. HCV is completely curable and testing and treatment are the path to cure. OTPs play a critical role in comprehensive approaches to addressing HCV and this guide is one tool to help.  

    DESCRIPTION:  In this webinar, Dr. Ryan Westergaard will review the epidemiology of HIV and Hepatitis C infection among people who use drugs. He will discuss current and future approaches for addressing infectious disease risks as the epidemics of opioid and stimulant use continue to evolve, sharing research findings from the National Institutes of Health Rural Opioid Initiative.  With examples from community-based research conducted in Wisconsin and elsewhere in the Midwest, Dr. Westergaard will illustrate how changes in injection drug use, policies around harm reduction services, and the COVID-19 pandemic influence communities’ vulnerability to HIV outbreaks and pose challenges to the national goal of viral hepatitis elimination.     LEARNING OBJECTIVES: Understand how changes in the epidemiology of opioid and methamphetamine use disorder have posed obstacles to the goals of ending the HIV epidemic. Recognize the potential impact of incorporating screening, linkage to care, and low-threshold treatment for hepatitis C infection in addiction treatment settings. Discuss a research agenda for a comprehensive, patient-centered approach to health and safety of people who inject drugs.       TRAINER: Dr. Ryan Westergaard, MD, PhD, MPH, is a physician and epidemiologist, specializing in treatment and prevention for HIV and viral Hepatitis, with a special dedication to harm reduction among people who inject drugs. He is currently serving as Wisconsin’s Chief Medical Officer for the Bureau of Communicable Diseases (DPH, DHS). This is in addition to his research and physician-faculty position at the University of Wisconsin Madison School of Medicine and Public Health where he’s an Associate Professor of Medicine and an Infectious Disease Physician for UW Health. Holding these positions has paved the way for building bridges between the institutions and leverage the many resources of all to benefit the health and well-being of residents across Wisconsin.         The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.

Throughout the month of September 2022, the Idaho Department of Health & Welfare in partnership with Recovery Idaho, Idaho Harm Reduction Project, and the Northwest ATTC hosted a series of online webinars titled “Recovery is Health, Health is Recovery." During the series, presenters discussed a range of topics relating to transmissible disease, treatment and precautionary measures, as well as harm reduction practices. September 21, 2022 Presenter: Lindsay Haskell, Idaho Department of Health and Welfare In this session, Lindsay Haskell will provide an overview of basic sexual health concepts for individuals and providers, discuss other sexually transmitted infections, and dive into other infectious diseases that can be transmitted through intimate contact, like Monkeypox, Shigella, and Meningococcal disease. Read more about this session and its presenter. Watch the recording | Download slides  

Throughout the month of September 2022, the Idaho Department of Health & Welfare in partnership with Recovery Idaho, Idaho Harm Reduction Project, and the Northwest ATTC hosted a series of online webinars titled “Recovery is Health, Health is Recovery." During the series, presenters discussed a range of topics relating to transmissible disease, treatment and precautionary measures, as well as harm reduction practices. September 14, 2022  Presenter: DaNae Schoenborn, Idaho Department of Health and Welfare In this session, DaNae Schoenborn will raise awareness about viral hepatitis, reduce the stigma surrounding hepatitis, educate about prevention efforts, and hopefully inspire community members to continue the conversation. Read more about this session and its presenter. Watch the recording | Download slides  

Throughout the month of September 2022, the Idaho Department of Health & Welfare in partnership with Recovery Idaho, Idaho Harm Reduction Project, and the Northwest ATTC hosted a series of online webinars titled “Recovery is Health, Health is Recovery." During the series, presenters discussed a range of topics relating to transmissible disease, treatment and precautionary measures, as well as harm reduction practices. Part 5: September 21, 2022 Presenter: Lindsay Haskell, Idaho Department of Health and Welfare In this session, Lindsay Haskell will provide an overview of basic sexual health concepts for individuals and providers, discuss other sexually transmitted infections, and dive into other infectious diseases that can be transmitted through intimate contact, like Monkeypox, Shigella, and Meningococcal disease. Read more about this session and its presenter. Watch the recording | Download slides  

Throughout the month of September 2022, the Idaho Department of Health & Welfare in partnership with Recovery Idaho, Idaho Harm Reduction Project, and the Northwest ATTC hosted a series of online webinars titled “Recovery is Health, Health is Recovery." During the series, presenters discussed a range of topics relating to transmissible disease, treatment and precautionary measures, as well as harm reduction practices. Part 3: September 14, 2022  Presenter: DaNae Schoenborn, Idaho Department of Health and Welfare In this session, DaNae Schoenborn will raise awareness about viral hepatitis, reduce the stigma surrounding hepatitis, educate about prevention efforts, and hopefully inspire community members to continue the conversation. Read more about this session and its presenter. Watch the recording | Download slides

This presentation reviewed the philosophy of harm reduction as an intervention for substance use disorder and will examine the trajectory of harm reduction programming in Idaho since the legalization of syringe services in 2019.  A few learning objectives:  Be able to identify multiple forms of harm reduction as it pertains to a variety of potentially risky behaviors. Be able to reframe substance use from a harm reduction model. Be able to identify the benefits of a syringe service program and other harm reduction interventions to an individual and a community. Increase knowledge about the implementation and growth of harm reduction programs in Idaho. About the presenter: Marjorie Wilson, LMSW, MPH, is the Executive Director and co-founder of Idaho Harm Reduction Project (IHRP). IHRP is a drug user health program offering a syringe service program, naloxone distribution program, and HIV/HCV testing. Since 2019, IHRP has served the whole state through its mail-based services and has distributed supplies into all of Idaho's 44 counties. Download slides | Watch recording

  The Great Lakes Current is the e-newsletter of the Great Lakes ATTC, MHTTC, and PTTC.   The August 2022 issue features content related to the nationwide transition to the 988 Suicide and Crisis Lifeline, the Great Lakes MHTTC's newly released Classroom WISE Discussion Guide, the new CDC drug overdose disparities report, and SAMSHA's "Talk. They Hear You."® youth substance use prevention campaign. You will also find links to all the upcoming events and trainings for the Great Lakes ATTC, MHTTC, and PTTC. 

    The Great Lakes Current is the e-newsletter of the Great Lakes ATTC, MHTTC, and PTTC.   The July 2022 issue features content related to Minority Mental Health Awareness Month, World Hepatitis Day (July 28), Naloxone Vending Machine (NVM) Implementation, and the new Comprehensive Culturally Responsive Glossary. You will also find links to all the upcoming events and trainings for the Great Lakes ATTC, MHTTC, and PTTC. 

Mid-America ATTC is please to promote a new training series offered through a collaboration between the Missouri Department of Health and Senior Services, MO Healthnet, Missouri Telehealth Network’s Show-Me ECHO, Missouri Primary Care Association, Mid-America Addiction Technology Transfer Center, and Swope Health. This training will be at no cost to the provider and will provide information on hepatitis C testing, linkage to care, and treatment. It will also equip the provider with tools on how to implement a hepatitis C clinic and expand provider capacity within Missouri to serve individuals who need hepatitis C treatment.  With the general rise in hepatitis C cases, more providers are needed to treat hepatitis C. A provider does not need to be a specialist to treat hepatitis C. With advancement of medicines, education and resources, treatment of hep C is easier than before! The weekly, four-part webinar series will be held four consecutive Fridays in October from 12-1 p.m. Continuing education credits will be provided for CME/Pharmacy hours. Sessions will be recorded for later viewing, but training participants must attend live for continuing education credits. Download the flyer to for training schedule and registration information. 

This session is designed for professionals who work with those at risk for contracting Hepatitis C Virus (HCV). An overview of HCV: risk; transmission; symptoms; testing; and treatment options will be provided. In addition, a discussion of harm reduction strategies and support/linkages to care will be included.   At the end of the webinar participants will be able to: Appreciate the importance of Hepatitis C Virus (HCV) screening and confirmatory testing in multiple health and behavioral health settings. Recognize risk factors for HCV Describe harm reduction strategies that minimize the risk of contracting HCV List treatment options available for people with HCV. Discuss strategies to link persons with HCV to HCV-focused health care services      

This three-part series will focus on the principles of harm reduction and its strategies to advance holistic services for individuals with substance use disorder (SUDs). Research indicates that harm reduction programs are evidence-based public health strategies designed to prevent overdose deaths, infectious disease, sexually transmitted infections, pregnancies, and injection drug use. For example, expanding access to naloxone for individuals using opioids is considered a harm reduction strategy. Specifically, this webinar series will include: an overview of the principles of harm reduction and their application in a harm reduction center; the importance of engaging law enforcement especially in rural areas and co-responder models; and a panel of experts discussing their expertise in offering harm reduction strategies in their service delivery as well as a consumer of harm reduction services.   Session One March 30, 2021, from noon to 1:00 MT, will feature Lisa Raville, Executive Director of the Harm Reduction Action Center in Denver, CO. Ms. Raville will provide an overview of the principles of harm reduction.   The learning objectives include: -An examination of the principles and evidence for the application of harm reduction strategies. -The role of harm reduction programs in eliminating stigma and shame. -Strategies to work cross-systems to advance harm reduction. -Data from a recent survey of healthcare workers.   Video Link Session Two April 13, 2021, from noon to 1:00 MT, will feature Chief Rick Brandt, Chief of Police in Evans, CO. Chief Brandt will provide content specific to engagement with law enforcement in harm reduction to include:  -Strategies to educate law enforcement on harm reduction in rural communities. -Content on how to implement harm reduction in a PD and the leadership strategies employed. -The role of law enforcement in working cross-system to prevent overdose deaths. -Application of co-responder models. Video Link   Session Three April 27, 2021, from noon to 1:30 MT, will feature a panel discussion to include the following panelists: (1) Lisa Raville, Executive Director of the Harm Reduction Action Center in CO, (2) Chris Harsell, ATTC Technical Trainer and Medical Director for Spectra Health in ND, (3) Gabriela Zapata-Alma, Director of Policy and Practice on Domestic Violence and Substance Use for the National Center on Domestic Violence, Trauma, and Mental Health in Chicago, Il, (4) and a consumer of harm reduction services. The focus will be on: -Responding to questions surrounding implementation strategies. -Community and consumer benefits of harm reduction services. -How harm reduction can be employed in any agency. Video Link

Objetivos: Repasar el uso y abuso de las sustancias ilegales durante el embarazo Presentar nuestro conocimiento la identificación y manejo de la Hepatitis C durante el embarazo Actualizar nuestro conocimiento con respecto a la pandemia del virus COVID 19 y su impacto en las mujeres embarazadas   Recursos Addicionales: Webinar slide handouts Not all vaccines are created equal Society for Maternal-Fetal Medicine (SMFM) Statement: SARS-CoV-2 Vaccination in Pregnancy Labor and Delivery COVID-19 Considerations WHO FAQ Website: Coronavirus disease (COVID-19): Vaccines   Presentador: Luis A. Izquierdo, M.D.

Objectives: Review the use and abuse of illegal substances during pregnancy. Address the identification and management of Hepatitis C during pregnancy Present our current knowledge of COVID-19 pandemic and its impact on pregnant patients   Additional Resources Webinar slide handouts Not all vaccines are created equal Society for Maternal-Fetal Medicine (SMFM) Statement: SARS-CoV-2 Vaccination in Pregnancy Labor and Delivery COVID-19 Considerations WHO FAQ Website: Coronavirus disease (COVID-19): Vaccines   Translations     Presenter: Luis A. Izquierdo, M.D.

This guide is intended to build the capacity of publicly funded Opioid Treatment Programs (OTPs) to integrate Hepatitis C Virus (HCV) prevention and treatment services into their programs. The guide may also be useful for Federally Qualified Health Centers (FQHCs), community and healthcare coalitions, nonprofit organizations and other substance use disorder and HCV treatment providers. The opioid epidemic has resulted in significant increases in HCV among people who inject drugs, accounting for 23% of new infections. HCV is completely curable and testing and treatment are the path to cure. OTPs play a critical role in comprehensive approaches to addressing HCV and this guide is one tool to help.

This 6-hour face-to-face training curriculum was recently updated in 2019 and includes the latest in treatment options available and the impact of the opioid epidemic on HCV in the U.S. The course is designed to instruct behavioral health and medical providers on hepatitis C (HCV) epidemiology, opportunities for promoting HCV screening and testing, treatment options and considerations, and linking persons infected to HCV health care. By the end of this training, participants should be able to:   List at least three populations impacted by the opioid crisis, 2019. List at least three infections that result from injection drug use. Discuss at least two reasons why it is important to promote hepatitis C screening and confirmatory diagnostic testing. Describe at least three prevention messages that can be used when promoting hepatitis C screening and testing. List at least three treatment factors to consider and describe at least two new treatment options available for patients with HCV. Provide examples of at least three strategies to link persons infected with HCV to HCV-focused health care.   Request a Hepatitis C training by contacting the ATTC in your Region.      

Hepatitis C virus is on the rise in rural communities of the U.S. This presentation from Judith Tsui, MD, MPH (University of Washington School of Medicine) described the syndemic of opioid use disorder (OUD) and hepatitis C (HCV). Dr. Tsui presented evidence showing the current gaps in treatment for OUD and HCV among persons who inject drugs. Based on analysis of current treatment methods and real-world patient living conditions, her presentation also described research on innovative models of care to improve treatment access and outcomes for persons with OUD and HCV. This webinar was sponsored by the Northwest ATTC and the Area Health Education Center for Western Washington (AHECWW).

Fueled by the opioid epidemic, hepatitis C infections have increased dramatically in rural communities in the Great Lakes Region. Since 2017, a consortium of academic, public health and community-based partners have undertaken abroad research program in six rural Wisconsin counties. The research team has surveyed more than 800 people who inject drugs and interviewed diverse stakeholders working on the public opioid response to inform best practices for reducing the spread of HIV, hepatitis and preventing overdose. In this 60-minute webinar, Principal Investigator Dr. Ryan Westergaard will review lessons learned through this research and describe how the communities plan to move forward with implementation of a client-centered prevention service coordination intervention starting in late 2019. PowerPoint Presentation Transcript  

Learn how addiction and infectious disease interact: Dr. Ryan Westergaard presents clinical issues related to the management of patients with infectious diseases and addiction, including important drug interactions, adherence support, and care coordination strategies.  Read the transcript: 

This webinar, presented on December 19, 2018 by Mary Hatch-Maillette, PhD, described how and why SUD treatment counselors should strive for greater comfort and ease in talking to patients about their sexual risk behavior. This includes how counselors can improve their own skill and comfort, a description of the MI Spirit approach, and how they can better link sexual risk with substance use, treatment and recovery when talking with their patients. About the presenter: Mary Hatch-Maillette, PhD, is the co-director of the NIDA Clinical Trials Network's Pacific Northwest Node, and a researcher at the University of Washington Addictions, Drug & Alcohol Institute. She specializes in substance use treatment, HIV risk behavior, and counselor workforce issues. She is also in private psychotherapy practice in Seattle. Download slides | Watch recording  

This list is prepared by the Division of Viral Hepatitis and the National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention. It contains the state/city, the Program Manager Coordinator, e-mail address, phone number and website.

Our nation's battle plan for fighting viral hepatitis in the United States. The updated plan outlines strategies to achieve four major goals and includes indicators to help track progress between now and 2020. The goals are: Goal 1: Prevent new viral hepatitis infections Goal 2: Reduce deaths and improve the health of people living with viral hepatitis Goal 3: Reduce viral hepatitis health disparities Goal 4: Coordinate, monitor, and report on implementation of viral hepatitis activities